loader2
Partner With Us NRI

Neogen Chemicals Ltd share Price Today

Company details

1,461.25
1,498.55
1,176.00
1,859.30
6M Return 8.60%
1Y Return -14.45%
Mkt Cap.(Cr) 3,870.64
Volume 77,787
Div Yield 0.14%
OI
-
OI Chg %
-
Volume 77,787

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Growth momentum maintained; focus on new capex
About The Stock

    Commencing operations in 1991, Neogen Chemicals manufactures specialty organic bromine-based chemical compounds as well as specialty inorganic lithium-based chemicals compounds.

    • The company’s products find application in pharmaceutical intermediates, agrochemical intermediates, engineering fluids, polymers additives and water treatment chemicals, to name a few
    • Neogen has two segments viz. (i) organic chemicals, (ii) inorganic chemicals of which organic chemical constitute ~80% of overall revenue while the rest comes from inorganic chemicals
Q3FY23

    Numbers were marginally in line with our estimates on the revenue front while EBITDA came in below estimates due to lower GPM.

    • Reported revenue growth of 40% YoY to ₹ 186.3 crore, led by higher growth from both organic chemicals ₹ 136 crore (up 29% YoY) and inorganic chemicals ₹ 50.3 crore (up 86% YoY)
    • Gross margins fell 91 bps YoY to 43.2% while EBITDA margin declined 177 bps YoY to 16.2%. Absolute EBITDA was up 27% YoY to ₹ 30.1 crore
    • PAT increased 41% YoY to ₹ 14.8 crore

Click here for full recommendation

Research view on more stocks

Speciality Chemicals company Neogen Chemicals announced Q1FY25 results:

  • In Q1FY25, revenue was higher by 9% to Rs 180.0 crore despite challenging operating scenario.
  • EBITDA stood at Rs 30.8 crore, an increase of 10% YoY. This improved despite higher employee costs and other expenses, in-line with capacity build up efforts in Neogen Ionics.
  • Margins were maintained at 17.1% YoY led by operational efficiencies, even as pricing pressures continued across key products.
  • Profit after Tax (PAT) grew by 18% to Rs 11.5 crore. PAT performance reflects the strong operating trend, further boosted by lower tax rate. Depreciation and interest expenses are expected to rise with accelerated CAPEX trajectory in Battery Chemicals.
  • Earnings per share (EPS) for Q1FY25 stood at Rs 4.35 per share (Rs. 3.92 per share in Q1FY24).

Commenting on the Q1FY25 performance, Haridas Kanani, Chairman & Managing Director, Neogen Chemicals said: “We are pleased to report 9% revenue growth and 18% PAT improvement this quarter. This was driven by gradual demand recovery with better volumes amid soft pricing. Effective supply chain management amidst logistical challenges strengthened customer relationships. Both BuLi Chem and Neogen Ionics contributed positively to the overall consolidated performance.

Our growth initiatives are on track, with initial capacities for Lithium Electrolyte Salts and Electrolytes now operational. We are shipping Lithium Saltsto global customers commercially, while Electrolytes are in trial production with commercial quantities aligned with upcoming cell production capacities in India. These efforts provide valuable market insights for our upcoming greenfield plant using MUIS technology, where construction has commenced. I am glad to share that we are one of the first companies in India whose Electrolyte supplied from the commercial plant is meeting global standards. We are proud to support India’s efforts for self-reliance in Lithium-ion battery manufacturing.

To mitigate current agchem market challenges in the existing business, we are looking at nonagchem opportunities until the global agchem market recovers and remain confident of achieving Rs 900-1,000 crore in revenues in FY26 based on anticipated recovery in the later half of this financial year.

We are steadily recovering from the ongoing macro challenges and anticipate stronger growth going ahead. Notwithstanding the current operating environment, we believe that Indian chemical industry is on the cusp of exponential growth in the long run. Neogen Chemicals will pursue all avenues to outperform and create enduring value for its stakeholders.”

Result PDF

View Other Company Results

Neogen Chemicals Ltd shares SWOT Analysis

Strengths (4)

  • Rising Net Cash Flow and Cash from Operating activity
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge

Weakness (4)

  • Inefficient use of assets to generate profits - ROA declining in the last 2 years
  • Low Piotroski Score : Companies with weak financials
  • Weak Momentum: Price below Short, Medium and Long Term Averages

Opportunity (1)

  • Street Favorite: High Analyst Rating with at least 20% upside

Threats (2)

  • High PE (PE > 40)
  • RSI indicating price weakness

Resistance and support

R1 1,490.1
R2 1,513.0
R3 1,527.4
Pivot

1,475.65

S1 1,452.8
S2 1,438.4
S3 1,415.5
EMA SMA
1,536.5
1,561.5
1,541.3
1,516.9
1,560.8
1,593.2
1,546.9
1,474.6
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
CUSTODY BANK OF JAPAN LTD RE RB AMUNDI INDIA SMALL CAP EQUITY MOTHER FUND Bulk Purchase 2024-06-28 1610 770000 NSE
INDIA ACORN ICAV Bulk Purchase 2024-06-28 1610 251900 NSE
SETU SECURITIES PVT LTD Bulk Purchase 2024-06-28 1613.63 195153 NSE
Name Category Shares
Haridas Thakarshi Kanani PROMOTER 45.11%
Harin Haridas Kanani PROMOTER 7.58%
Pallika Haridas Kanani PROMOTER 3.78%

OUR RESEARCH VIEW

Investment recommendation
Growth momentum maintained; focus on new capex
Call Date
20 Feb 2023
Entry Price 1,295.00
Target Price 1,535.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Neogen Chemicals Ltd Stocks COMPARISON

Financials( in Cr) Neogen Chemicals Ltd Pidilite Industries Ltd SRF Ltd Linde India Ltd Gujarat Fluorochemicals Ltd
Price 1,467.15 3,233.70 2,509.05 7,385.75 3,808.90
% Change -1.74 0.76 -4.18 -0.72 8.08
Mcap Cr 3,870.64 164,468.89 74,374.51 62,988.63 41,840.77
Revenue TTM Cr 686.18 12,382.99 13,138.52 2,768.67 5,684.66
Net Profit TTM Cr 49.97 1,747.42 1,335.71 434.09 1,323.05
PE TTM 103.54 87.63 60.55 140.59 122.41
1 Year Return -14.45 29.80 3.70 11.81 25.56
ROCE 13.01 29.30 12.52 17.04 29.38
ROE 10.84 22.37 12.25 13.14 27.07
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 482.52 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,795.20 31,732.91
LAST 3M 82,219.63 37,844.71
LAST 6M 195,814.55 51,713.96
LAST 12M 324,182.79 93,986.84
Neogen Chemicals Limited - Copy of Newspaper Publication

Sep 04, 2024 l NSE Announcement

Neogen Chemicals Limited - Updates

Sep 03, 2024 l NSE Announcement

Neogen Chemicals Limited - Analysts/Institutional Investor Meet/Con. Call Updates

Sep 02, 2024 l NSE Announcement

Date Action Type Ratio
Sep 19, 2024 Dividend 20
Aug 25, 2023 Dividend 30
Sep 19, 2022 Dividend 27.5

Neogen Chemicals Ltd Information

Stock PE (TTM)
103.54
Promoter Holding
56.89%
Book Value
288.1893
ROCE
13.01%
ROE
10.84%
Description
  • Neogen Chemicals Limited was incorporated as a Private Limited Company with the name `Neogen Chemicals Private Limited` on March 7, 1989 in Thane, Maharashtra. Subsequently, Company was converted to a Public Limited Company and the name of the Company was changed to `Neogen Chemicals Limited` on July 2, 1998. Neogen is one of India`s leading manufacturers of bromine-based compounds, lithium and bromine salts and grignard chemicals. Specialty chemicals are those chemicals that impart different properties to a variety of products (i.e. the effect that specialty chemicals have varies based on the product) and have a high degree of value addition. Specialty chemicals are manufactured in smaller volumes when compared to non-specialty chemicals. Specialty chemicals, including bromine and lithium-based compounds, comprise pharmaceutical intermediates, agrochemical intermediates, engineering fluids, electronic chemicals, polymers additives, water treatment chemicals, construction chemicals and flavours and fragrances. The Company commenced its business operations in 1991, at Mahape, in Navi Mumbai manufacturing facility with a few Bromine Compounds and Lithium Compounds. In addition to manufacturing its standard products, the company undertakes custom synthesis and contract manufacturing. In custom synthesis the product is developed and customized primarily for a specific customer, but process know-how and technical specifications are developed in-house by the company. Further, it also commenced contract manufacturing where, the product is developed under confidentiality for a single customer using the process know-how and the technical specifications provided by customer. Contract manufacturing enabled to increase its bouquet of product offering. The Company differentiates itself in the contract manufacturing space by additionally offering process innovation, which, generally, reduces the overall operating costs for their customers. The Company operates out of its manufacturing facilities located in Mahape, Navi Mumbai in Maharashtra (Mahape Facility) and Karakhadi, Vadodara in Gujarat (Vadodara Facility). Company is, presently, developing a green-field manufacturing unit in Dahej SEZ, in Gujarat (Proposed Dahej Facility). In April 2019, the Company came out with an Initial Public Offering of 6,155,813 equity shares by raising equity capital from public aggregating Rs 132.35 Crores. The offer comprises of a fresh issue of 3,255,813 equity shares aggregating Rs 70 crores by the company and an offer for sale of 1,699,600 equity shares by Haridas Thakarshi Kanani (promoter selling shareholder) and 1,200,400 equity shares by Beena Haridas Kanani (promoter group selling shareholder, and along with the promoter selling shareholder aggregating Rs 62.35 Crores. The Company started the Organic Chemical production at Dahej SEZ (Gujarat) in April 2021. The aggregate manufacturing capacity of Inorganic Chemicals was doubled to 2,400 MT p.a. after the commencement of its operations in Feb 2020. In 2021-22, the Company began with Phase I and Phase II commercial operations of Organic Chemicals at full scale at Dahej SEZ plant. With completion of Phase I and Phase II Expansions and other brownfield expansions, the total organic chemicals manufacturing capacity of the Company increased from 130 Kilo litres of Reactor capacity to 407 Kilo litres of Reactor capacity. The Company acquired 100% stake in BuLi Chemicals India Private Limited and it became the wholly-owned subsidiary of the Company in 2023. The Company forayed into the electrolyte market by signing an agreement with Japan-based MU Iconic Solutions Corporation to acquire a manufacturing technology licence to make electrolytes for lithium-ion batteries for vehicles in India. The Company further incorporated a Wholly Owned Subsidiary of the Company on March 29, 2023, named "Neogen Ionics Limited".

Registered Address

1002 10th Flr Opp Cadbury Junc, Dev Corpora Bldg Off Pok RdNo2, Thane, Maharashtra, 400601

Tel : 91-22-2549 7300
Email : investor:neogenchem.com
Website : http://www.neogenchem.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 542665
NSE Code : NEOGEN
Book Closure Date (Month) : Aug/Sep
BSE Group : A
ISIN : INE136S01016

FAQ’s on Neogen Chemicals Ltd Shares

You can buy Neogen Chemicals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Neogen Chemicals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Sep 06, 2024 04:03 PM the closing price of Neogen Chemicals Ltd was Rs.1,467.15.

The latest PE ratio of Neogen Chemicals Ltd as of Sep 06, 2024 04:03 PM is 103.54

The latest PB ratio of Neogen Chemicals Ltd as of Sep 06, 2024 04:03 PM is 0.20

The 52-week high of Neogen Chemicals Ltd share price is Rs. 1,859.30 while the 52-week low is Rs. 1,176.00

According to analyst recommendations, Neogen Chemicals Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 06, 2024 04:03 PM, the market cap of Neogen Chemicals Ltd stood at Rs. 3,870.64 Cr.

Download App

Download Our App

Play Store App Store
market app